Keywords: Prostate, Prostate
Motivation: The detection rate of csPCa in PI-RADS 3 lesions is only 25-38%. This leads to unnecessary biopsies.
Goal(s): Can multiparametric quantitative maps based on estimated T1 and T2 help differentiate clinically significant prostate cancer (csPCa) from non-csPCa in PI-RADS 3 lesions?
Approach: We compare T1, T2, and ADC obtained from Multiple-Repetition time Multiple- Echo time (MRME) based DWI (MRME-DWI) between csPCas and non-csPCas in PI-RADS 3 lesion using MRI-ultrasound fusion targeted biopsy as the reference standard.
Results: The T1, T2, and ADC were significantly lower for csPCas than non-csPCas. Combining these indices yields an AUC of 0.82.
Impact: MRME-DWI can simultaneously obtain T1, T2, and ADC from a single region of interest in a single imaging session. Combining these quantitative measures is expected to improve the detection rate of clinically significant prostate cancer in PI-RADS 3 lesions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords